<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To examine metabolic changes (<z:chebi fb="23" ids="18059">lipids</z:chebi>, liver enzymes, blood pressure, and weight) potentially associated with conversion to <z:mp ids='MP_0002055'>diabetes</z:mp>, we analyzed serial <z:chebi fb="105" ids="17234">glucose</z:chebi> and other metabolic measures obtained every 6 months within the West of Scotland Coronary Prevention Study trial </plain></SENT>
<SENT sid="1" pm="."><plain>Changes in parameters for 86 men who converted to new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp> ("converters": two consecutive <z:chebi fb="105" ids="17234">glucose</z:chebi> levels &gt; or =7 mmol/l) were compared with 860 "nonconverters" matched for age and treatment allocation </plain></SENT>
<SENT sid="2" pm="."><plain>Eighteen months before the diagnosis, converters to <z:mp ids='MP_0002055'>diabetes</z:mp> had elevated (P &lt; 0.01) fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, weight, <z:chebi fb="0" ids="17855">triglyceride</z:chebi>, alanine aminotransferase (ALT), blood pressure, and white cell count and lower <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> compared with nonconverters </plain></SENT>
<SENT sid="3" pm="."><plain>The mean (SD) increase in fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> over 18 months in converters was 1.80 (1.52) mmol/l, compared with 0.10 (0.57) in nonconverters </plain></SENT>
<SENT sid="4" pm="."><plain>Of parameters measured, only ALT (P = 0.0005) and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (P = 0.030) increased significantly more over the 18 months in converters compared with nonconverters, but neither parameter increased significantly in nonconverters with high baseline <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations (&gt;6.1 mmol/l) </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, only sustained increases in ALT predicted a higher risk for <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that a relatively rapid rise in fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> levels is frequent in converters to <z:mp ids='MP_0002055'>diabetes</z:mp> and that associated increases over time in ALT and potentially <z:chebi fb="0" ids="17855">triglyceride</z:chebi> suggest hepatic fat accumulation as a contributing factor for conversion to <z:mp ids='MP_0002055'>diabetes</z:mp> in men at risk </plain></SENT>
</text></document>